All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Apolipoproteins are associated with new MRI lesions and deep grey matter atrophy in clinically isolated syndromes

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F14%3A10272326" target="_blank" >RIV/00216208:11110/14:10272326 - isvavai.cz</a>

  • Alternative codes found

    RIV/00064165:_____/14:10272326

  • Result on the web

    <a href="http://dx.doi.org/10.1136/jnnp-2013-307106" target="_blank" >http://dx.doi.org/10.1136/jnnp-2013-307106</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1136/jnnp-2013-307106" target="_blank" >10.1136/jnnp-2013-307106</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Apolipoproteins are associated with new MRI lesions and deep grey matter atrophy in clinically isolated syndromes

  • Original language description

    Objectives: There is increasing evidence that serum lipoprotein cholesterol biomarkers are associated with disease progression in clinically isolated syndromes (CIS). Apolipoproteins (Apo) are recognition ligands that mediate the physiological interactions of cholesterol-containing lipoproteins. The objective of this study was to investigate whether serum Apo levels are associated with CIS disease progression. Methods: ApoB, ApoAI, ApoAII, ApoE and lipoprotein (a) (Lpa) levels were measured in serum samples obtained prior to the start of treatment from 181 CIS patients (123 women, 58 men, 68% women; mean age: 28.1+-SD 8.1 years). All patients were treated with intramuscular interferon-? as part of the prospective study. Clinical and MRI assessments were obtained at baseline, 6, 12 and 24 months after start of interferon-? treatment. Results: Greater ApoB levels were associated with increased number of new T2 lesions (p<0.001) and increased number of new or enlarging T2 lesions (p<0.001

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

  • CEP classification

    FH - Neurology, neuro-surgery, nuero-sciences

  • OECD FORD branch

Result continuities

  • Project

    <a href="/en/project/NT13237" target="_blank" >NT13237: Clinical and paraclinical markers of multiple sclerosis – description and prediction of disease activity</a><br>

  • Continuities

    Z - Vyzkumny zamer (s odkazem do CEZ)<br>S - Specificky vyzkum na vysokych skolach<br>I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2014

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Journal of Neurology, Neurosurgery and Psychiatry

  • ISSN

    0022-3050

  • e-ISSN

  • Volume of the periodical

    85

  • Issue of the periodical within the volume

    8

  • Country of publishing house

    GB - UNITED KINGDOM

  • Number of pages

    6

  • Pages from-to

    860-865

  • UT code for WoS article

    000342428500052

  • EID of the result in the Scopus database